-
-
-
-
-
-
-
Alexion Pharma (ALXN): Raising PT On Soliris Label Expansion - Baird
-
-
-
-
-
-
-
Alexion Pharma (ALXN): Alnylam Misstep with ALN-CC5 Does Not Make ALXN a Buy - Baird
-
-
-
-
-
-
-
Baird Bullish on Alexion (ALXN), Says Beat & Raise Will Be Pattern
-
-
-
-
-
-
-
Baird Reiterates a 'Neutral' on Alexion Pharmaceuticals (ALXN); Soliris Priority Review in aHUS Fully Expected
-
-
-
-
22,802 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All